Cognizant has signed a new tech contract with Organon, a global women’s health company, to improve delivery of healthcare products and medicinal supply chain management.
Cognizant, a leading IT services company, will help scale Organon’s healthcare business by delivering full-stack industrial technology support for its pharmaceutical manufacturing sites in the United Kingdom, Netherlands, Belgium and Indonesia.
This includes managing Organon’s manufacturing systems with SAP’s S4/HANA enterprise application suite. Cognizant said it seeks to help Organon enhance supply chain oversight, increase medicinal yields, reduce cycle times and get products to patients faster.
Rachel Stahler, Chief Information Officer at Organon, said: “By partnering with Cognizant, we have teamed up with one of world’s top technology and professional services companies to advance our digital ambitions and capabilities, along with speeding access to important therapies for women everywhere.”
“Our work with Organon to align its pharmaceutical development with Industry 4.0 principles is crucial to supporting women’s health in an efficient, expedient and compliant approach,” said Surya Gummadi, Cognizant’s SVP of Global Health Sciences and SVP, Americas.
Cognizant claims that it works with each of the world’s top 30 pharmaceutical companies. Its 2019 acquisition of Zenith Technologies has enabled Cognizant to become one of the only global organizations capable of providing end-to-end support for pharmaceutical manufacturing systems.
Cognizant competes with Accenture, IBM, Infosys, Wipro, TCS, HCL Technologies, among others.
